Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE)
Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of ...